MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures

<p>Abstract</p> <p>Background</p> <p>The presence of <it>MLL </it>rearrangements in acute leukemia results in a complex number of biological modifications that still remain largely unexplained. Armstrong et al. proposed <it>MLL </it>rearrangement...

Full description

Bibliographic Details
Main Authors: te Kronnie Geertruy, Dell'Orto Marta, Zangrando Andrea, Basso Giuseppe
Format: Article
Language:English
Published: BMC 2009-06-01
Series:BMC Medical Genomics
Online Access:http://www.biomedcentral.com/1755-8794/2/36
_version_ 1811189368088428544
author te Kronnie Geertruy
Dell'Orto Marta
Zangrando Andrea
Basso Giuseppe
author_facet te Kronnie Geertruy
Dell'Orto Marta
Zangrando Andrea
Basso Giuseppe
author_sort te Kronnie Geertruy
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The presence of <it>MLL </it>rearrangements in acute leukemia results in a complex number of biological modifications that still remain largely unexplained. Armstrong et al. proposed <it>MLL </it>rearrangement positive ALL as a distinct subgroup, separated from acute lymphoblastic (ALL) and myeloblastic leukemia (AML), with a specific gene expression profile. Here we show that MLL, from both ALL and AML origin, share a signature identified by a small set of genes suggesting a common genetic disregulation that could be at the basis of mixed lineage leukemia in both phenotypes.</p> <p>Methods</p> <p>Using Affymetrix<sup>® </sup>HG-U133 Plus 2.0 platform, gene expression data from 140 (training set) + 78 (test set) ALL and AML patients with (24+13) and without (116+65) <it>MLL </it>rearrangements have been investigated performing class comparison (SAM) and class prediction (PAM) analyses.</p> <p>Results</p> <p>We identified a <it>MLL </it>translocation-specific (379 probes) signature and a phenotype-specific (622 probes) signature which have been tested using unsupervised methods. A final subset of 14 genes grants the characterization of acute leukemia patients with and without <it>MLL </it>rearrangements.</p> <p>Conclusion</p> <p>Our study demonstrated that a small subset of genes identifies <it>MLL</it>-specific rearrangements and clearly separates acute leukemia samples according to lineage origin. The subset included well-known genes and newly discovered markers that identified ALL and AML subgroups, with and without <it>MLL </it>rearrangements.</p>
first_indexed 2024-04-11T14:33:50Z
format Article
id doaj.art-20926b4a8d874777a4d3eff08b4f9931
institution Directory Open Access Journal
issn 1755-8794
language English
last_indexed 2024-04-11T14:33:50Z
publishDate 2009-06-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj.art-20926b4a8d874777a4d3eff08b4f99312022-12-22T04:18:25ZengBMCBMC Medical Genomics1755-87942009-06-01213610.1186/1755-8794-2-36MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatureste Kronnie GeertruyDell'Orto MartaZangrando AndreaBasso Giuseppe<p>Abstract</p> <p>Background</p> <p>The presence of <it>MLL </it>rearrangements in acute leukemia results in a complex number of biological modifications that still remain largely unexplained. Armstrong et al. proposed <it>MLL </it>rearrangement positive ALL as a distinct subgroup, separated from acute lymphoblastic (ALL) and myeloblastic leukemia (AML), with a specific gene expression profile. Here we show that MLL, from both ALL and AML origin, share a signature identified by a small set of genes suggesting a common genetic disregulation that could be at the basis of mixed lineage leukemia in both phenotypes.</p> <p>Methods</p> <p>Using Affymetrix<sup>® </sup>HG-U133 Plus 2.0 platform, gene expression data from 140 (training set) + 78 (test set) ALL and AML patients with (24+13) and without (116+65) <it>MLL </it>rearrangements have been investigated performing class comparison (SAM) and class prediction (PAM) analyses.</p> <p>Results</p> <p>We identified a <it>MLL </it>translocation-specific (379 probes) signature and a phenotype-specific (622 probes) signature which have been tested using unsupervised methods. A final subset of 14 genes grants the characterization of acute leukemia patients with and without <it>MLL </it>rearrangements.</p> <p>Conclusion</p> <p>Our study demonstrated that a small subset of genes identifies <it>MLL</it>-specific rearrangements and clearly separates acute leukemia samples according to lineage origin. The subset included well-known genes and newly discovered markers that identified ALL and AML subgroups, with and without <it>MLL </it>rearrangements.</p>http://www.biomedcentral.com/1755-8794/2/36
spellingShingle te Kronnie Geertruy
Dell'Orto Marta
Zangrando Andrea
Basso Giuseppe
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
BMC Medical Genomics
title MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
title_full MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
title_fullStr MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
title_full_unstemmed MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
title_short MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
title_sort mll rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias mll specific and lineage specific signatures
url http://www.biomedcentral.com/1755-8794/2/36
work_keys_str_mv AT tekronniegeertruy mllrearrangementsinpediatricacutelymphoblasticandmyeloblasticleukemiasmllspecificandlineagespecificsignatures
AT dellortomarta mllrearrangementsinpediatricacutelymphoblasticandmyeloblasticleukemiasmllspecificandlineagespecificsignatures
AT zangrandoandrea mllrearrangementsinpediatricacutelymphoblasticandmyeloblasticleukemiasmllspecificandlineagespecificsignatures
AT bassogiuseppe mllrearrangementsinpediatricacutelymphoblasticandmyeloblasticleukemiasmllspecificandlineagespecificsignatures